Key facts
- Instalimb’s last known valuation is $23.0M (May 2025).
- It has raised $16.5M; the latest was Later Stage VC ($11.7M) in May 2025.
- Notable investors include Mitsubishi UFJ Capital, Global Brain, Mizuho Capital, J-Startup, Pegasus Tech Ventures — 27 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Instalimb
- ·The full record, as it builds
Funding rounds
No funding rounds for Instalimb are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Instalimb
Developer of a three-dimensional printing and machine learning technology designed to create low-cost prosthetics and orthotics for amputees. The company's technology produces prosthetic braces using three-dimensional printers and modeling software with shape recommendation functions based on an algorithm that reduces the cost to about one-tenth and the delivery time to be shortened, enabling patients to get prosthetics made out of advanced technology.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2017
- Employees
- 122
- Website
- instalimb.com/
- Ownership
- Privately Held (backing)
Instalimb doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Instalimb shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Instalimb in its N-PORT filings yet. We sweep new filings monthly.